Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, discusses the value of collaboration

03/18/2020

About Us Subs

Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, discusses the value of collaboration

2021 Inclusive Leadership Week: #ChooseToChallenge - Day 3

30 March 2021

Amgen to Acquire Rodeo Therapeutics Corporation

Full article

15 March 2021

Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I

Full article

©Johnson & Johnson Innovation LLC 2021. All Rights Reserved. Your use of the information on this site is subject to the terms of our Legal Notice. Please see our Privacy Policy and Do Not Sell My Personal Information form. This site is published by Johnson & Johnson Innovation LLC which is solely responsible for its contents. This site is intended for global audiences. Capitalized product names are trademarks of the Johnson & Johnson Family of Companies or its affiliates.

Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, discusses the value of collaboration

2021 Inclusive Leadership Week: #ChooseToChallenge - Day 3

2021 Inclusive Leadership Week: #ChooseToChallenge - Day 1

2021 Inclusive Leadership Week: #ChooseToChallenge - Kris Sterkens Opening Address

Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, discusses the value of collaboration

Related video

2021 Inclusive Leadership Week: #ChooseToChallenge - Day 3

Related article

Amgen to Acquire Rodeo Therapeutics Corporation

Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I

Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, discusses the value of collaboration

2021 Inclusive Leadership Week: #ChooseToChallenge - Day 3

2021 Inclusive Leadership Week: #ChooseToChallenge - Day 1

2021 Inclusive Leadership Week: #ChooseToChallenge - Kris Sterkens Opening Address

Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, discusses the value of collaboration

Related content

Related video

2021 Inclusive Leadership Week: #ChooseToChallenge - Day 3

Related article

Amgen to Acquire Rodeo Therapeutics Corporation

Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I